An outstanding clinic
The Foundation for the Study of Viral Hepatitis (FEHV) is a non-profit organization leader in the field of hepatology at international level, with the best specialists in liver diseases and molecular biology. In our clinic located in Madrid, we treat all kinds of liver diseases (autoimmune hepatitis, cholangitis, fatty liver, viral hepatitis, etc.).
At the FEHV Clinic we offer you the levels of quality and medical service that have made our team an international medical reference.
Complete genetic service applied to preventive diagnosis
Medical consultations with diagnosis and ambulatory and hospital treatment in various specialties: Hepatology, Digestive…
Liver biopsies and abdominal ultrasound
Dr. Vicente Carreño
Founder and president of the foundation for the study of viral hepatitis
Currently, he is considered one of the best hepatologists internationally. Dr. Carreño is a member of the European and American Societies for the Study of Liver Diseases. He trained as a doctor and received his doctorate in 1985 from the Faculty of Medicine of the Autonomous University of Madrid. He developed his international career in Research Centers in Oxford, Berlin and London.Read more about Dr. Vicente Carreño
Led by Dr. Vicente Carreño, we have three medical specialists in internal medicine, hepatology, digestive and nephrology, as well as specialists in the latest advances in radiology and ultrasound. We actively collaborate with the Biomedical Research Foundation, for advanced study in liver diseases and new diagnostic techniques.
REQUEST INFORMATION WITHOUT COMMITMENT
Learn more about liver diseases
In this section you can learn about diseases that mainly affect the liver and the digestive system. You can learn from the best specialists the details, treatments and cure of liver diseases.
What they say about us
Reasons to choose us
We analyze the possibility of contagion in children by not being vaccinated.
There have been some studies in different populations that evaluate the protection developed against COVID-19 after receiving the first or both doses of the vaccine.